Pharmaceuticals

Increasing Prevalence Of Obesity Fueling Growth Of The Due To Increasing Consumption Of High-Calorie Diets Is Supporting Expansion In The Pharmaceutical Excipients Market

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Pharmaceutical Excipients Market Progress Between 2026 And 2030?

The market size for pharmaceutical excipients has experienced significant expansion in recent years. Projections indicate it will expand from $10822.05 billion in 2025 to $11529.87 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.5%. Historically, this growth has been driven by factors such as the increasing demand for oral formulations, burgeoning pharmaceutical manufacturing in APAC, the adoption of synthetic excipients, stringent regulatory approvals, and rising research and development in drug formulation.

The pharmaceutical excipients market is projected to experience substantial growth in the upcoming years. This sector is anticipated to reach a valuation of $14867 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This expansion can be attributed to several factors, including the advancements in personalized medicine, a surge in biopharmaceutical production, the rising demand for natural and clean-label excipients, technological progress in excipient synthesis, and the growing influence of contract manufacturing organizations (CMOs). Major trends foreseen during this period encompass novel excipient formulations, enhanced solutions for drug stability, targeted drug delivery systems, the adoption of natural and plant-based excipients, and the development of multi-functional excipients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3415&type=smp

Which Primary Drivers Are Impacting The Pharmaceutical Excipients Market Growth?

The projected increase in biologics sales is anticipated to drive the pharmaceutical sterility testing market in the future. Biologics, or biological products, refer to medications derived from living organisms, encompassing various items such as vaccines, blood and its components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are incorporated into biologics to enhance stability, improve formulation, and ensure the optimal delivery of active biological agents. For example, in October 2024, data from the Generics and Biosimilars Initiative, a Belgium-based organization providing high-quality, scientific information on generic and biosimilar medicines, revealed that beyond the nine leading biologics, two additional complex drugs recorded significant sales in 2023. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both treatments for type 2 diabetes, achieved sales of US$14 billion and US$7.2 billion, respectively. This demonstrates that the surge in biologics sales is propelling the pharmaceutical excipients market.

How Are Segments Identified Within The Pharmaceutical Excipients Market Segment Framework?

The pharmaceutical excipients market covered in this report is segmented –

1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products

2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities

3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations

Subsegments:

1) By Inorganic Chemicals: Salts, Oxides, Silicates

2) By Organic Chemicals: Sugars, Polymers, Oils And Fats

3) By Other Products: Natural Excipients, Coatings, Antioxidants

Which Trends Are Shaping Growth In The Pharmaceutical Excipients Market?

Major companies within the pharmaceutical excipient market are introducing advanced excipients, such as high-purity variants, to improve drug formulation stability, boost bioavailability, and support complex drug delivery systems. High-purity excipients are defined as pharmaceutical excipients that have undergone extensive purification processes to eliminate impurities and contaminants. For example, in October 2023, Clariant, a specialty chemical company from Switzerland, released three new VitiPure excipients engineered to enhance the stability and solubility of active pharmaceutical ingredients (APIs). These offerings include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer with low bioburden. Aimed at various drug delivery applications, particularly for sensitive formulations like mRNA vaccines and biologics, these excipients address the increasing demand for high-purity components while meeting rigorous regulatory standards.

Who Are The Companies Competing Within The Pharmaceutical Excipients Market?

Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma

Get The Full Pharmaceutical Excipients Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Which Region Leads The Pharmaceutical Excipients Market In Overall Market Size?

North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceutical Excipients Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Browse Through More Reports Similar to the Global Pharmaceutical Excipients Market 2026, By The Business Research Company

Pharmaceutical Excipient Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

Organic Pharmaceutical Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/organic-pharmaceutical-excipients-global-market-report

Alcohol Excipients Market Report 2026

https://www.thebusinessresearchcompany.com/report/alcohol-excipients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795